September 25, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces that the Company has elected Mr. Carl-Åke Carlsson as its new Chairman of the Board of Directors.
September 1, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces that the Company has strengthened its management team with the appointment of Dr. Mads Aaboe Jensen as Vice President Business
An international and very diverse team is behind Zerion Pharma – a drug development company improving the formulation of poorly soluble drugs that are currently not reaching their therapeutical potential...
Ieva Jasiukenaite is joining ZERION’s commercial team as a Communications Specialist and Camila Belavi is joining ZERION’s R&D team as a Laboratory Technician. Both already joined ZERION during February and March...
Dr. Anis Arnous and Dr. Søren Vinter Søgaard will join ZERION’s R&D team as Analytical Scientist and Scientific Director...
In addition to being responsible for financial operations, Jakob Dynnes Hansen will assume a key role in ZERION’s next financing round in the first half of 2021. As responsible for regulatory affairs, Mónica...
